Increasing data point on PI3K pathways as anti-inflammatory targets in airway diseases, including asthma, allergic rhinitis, chronic obstructive pulmonary disease (COPD) and others. This evidence concerns the gene PIK3CD and chronic obstructive pulmonary disease.